What if I've already been told I'm not eligible for CAR-T therapy at another hospital?

Eligibility criteria can vary significantly between hospitals and depend on a patient's current condition at the time of assessment. ChinaCureLink can help arrange a fresh case review with a hospital experienced in managing complex, high-risk CAR-T cases.

Can elderly patients or those with heart conditions safely receive CAR-T therapy?

It depends on the individual case. Patients with cardiac history or other comorbidities require closer monitoring and a carefully managed bridging period, but as this case shows, age and heart conditions alone don't automatically rule out CAR-T therapy. A specialist evaluation is needed to assess individual risk.

How can international patients access CAR-T therapy for relapsed lymphoma in China?

Access typically starts with a case review, where medical records, pathology, and treatment history are submitted for evaluation. ChinaCureLink coordinates this process and helps match patients with hospitals experienced in complex or previously unsuccessful CAR-T cases.

top of page

ChinaCurelink
a MedeboundHEALTH Company

FREE CONSULTATION

Under 10% Odds: How CAR-T Achieved Complete Remission for a 70-Year-Old Lymphoma Patient in China

ChinaCureLink

Tue Sep 01 2026

7 min read

Widget Didn’t Load

Check your internet and refresh this page.

If that doesn’t work, contact us.

bottom of page